On November 25, 2022, Amlan International, a company specializing in toxin binders in the United States,

strengthened its strategic alliance with ACC and held a meeting on marketing plans in 2023.

The two companies discussed various promotional activities and events to be conducted in 2023 and established action plans.

Amlan is a world-class toxin binder company, and ACC introduced mycotoxin binder to Korea about 20 years ago to publicize the importance of mycotoxin.

Also, from December 12 to 13, 2022, we reviewed the 2022 business with Taiwanese company KGbio, and had a meeting about marketing strategy,

item expansion, and sales growth in 2023.

KGbio researched and developed VIVA, the latest product with a unique patent, and conducted exclusive sales in Korea through a partnership with ACC in 2022.

VIVA has been recognized for its effectiveness in laying hens and pigs by reducing the proliferation and damage of influenza virus based on its unique antiviral effect whose mechanism of action has been identified.

In particular, during this visit, we had a schedule to hold seminars with major feed companies in Korea.